Posters

Intracameral dexamethasone for hard cataract surgery with topical anesthesia: improving patient comfort

Poster Details

First Author: E. Sanz-Marco SPAIN

Co Author(s):    A. Hervas-Ontiveros   S. Garcia-Delpech   D. Salom-Alonso              

Abstract Details

Purpose:

To analyze effectiveness and safety of intracameral dexamethasone in hard cataract surgery using topical anesthesia.

Setting:

Study was carried out in Manises Hospital in Valencia, Spain.

Methods:

14 patients with hard cataract who underwent cataract surgery with topical anesthesia were included. Visthesia® (1.5% sodium hyaluronate and 2.0% lidocaine hydrochloride) was used during surgery, and dispersive viscoelastic, Z-Hyalcoat® (3% sodium hyaluronate) was used prior to phacoemulsification. 0.1ml intracameral dexamethasone was administered at the end of the cataract surgery prior to 0.1ml intracameral cefuroxime administration. No prophylactic intraocular pressure-lowering medication was used. Main outcomes were: best corrected visual acuity (BCVA), presence of corneal edema and intraocular pressure (IOP). Data were collected one day after surgery, one week after surgery and one month after surgery.

Results:

No increased intraocular pressure was observed during the follow-up, highest IOP registered was 25mmHg one day after surgery. Mean IOP was 18.21±3.70mmHg one day after surgery, 13.29±2.57mmHg one week after surgery and 13.50±2.57mmHg one month after surgery. 3 patients presented corneal edema one day after surgery, 2 patients one week after surgery, no patients presented corneal edema one month after surgery. Mean BCVA one month after surgery was 0.54±0.08.

Conclusions:

Intracameral dexamethasone is a safe, painless and effective alternative to subconjuntival or sub-Tenon injection of corticosteroids. More studies are needed to corroborate our conclusions.

Financial Disclosure:

NONE